Mphasis Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 11:19 am

Market Cap	43,737 Cr.
Current Price	2,302
High / Low	3,240/2,173
Stock P/E	26.5
Book Value	457
Dividend Yield	2.39 %
ROCE	24.0 %
ROE	18.4 %
Face Value	10.0
PEG Ratio	4.41

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Mphasis Ltd

Competitors of Mphasis Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
IDream Film Infrastructure Company Ltd	1.71 Cr.	114	114/85.0		295	0.00 %	%	%	10.0
I Power Solutions India Ltd	7.07 Cr.	15.9	15.9/10.3		8.99	0.00 %	3.67 %	3.83 %	10.0
Hypersoft Technologies Ltd	8.23 Cr.	19.4	19.4/7.00		5.13	0.00 %	8.57 %	10.7 %	10.0
Softtech Engineers Ltd	427 Cr.	333	612/268	180	99.6	0.00 %	6.40 %	2.79 %	10.0
Nucleus Software Exports Ltd	2,410 Cr.	900	1,645/791	16.0	268	1.39 %	32.0 %	24.0 %	10.0
Industry Average	163,391.62 Cr	928.76		44.27	141.06	0.61%	20.31%	16.92%	7.33

All Competitor Stocks of Mphasis Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	3,124	3,278	3,411	3,520	3,506	3,361	3,252	3,276	3,338	3,412	3,422	3,536	3,561
Expenses	2,571	2,701	2,811	2,902	2,889	2,763	2,665	2,681	2,737	2,773	2,804	2,888	2,883
Operating Profit	553	577	600	618	618	599	587	596	601	639	619	648	678
OPM %	18%	18%	18%	18%	18%	18%	18%	18%	18%	19%	18%	18%	19%
Other Income	31	39	36	43	40	43	50	49	54	64	74	59	63
Interest	22	21	23	26	24	24	24	34	53	50	50	40	39
Depreciation	83	80	80	80	82	83	87	89	103	131	105	104	132
Profit before tax	480	516	533	555	551	534	526	522	499	522	537	563	569
Tax %	25%	24%	25%	25%	25%	24%	25%	25%	25%	25%	25%	25%	25%
Net Profit	358	392	402	418	412	405	396	392	374	393	405	423	428
EPS in Rs	19.08	20.88	21.37	22.24	21.89	21.51	21.01	20.78	19.79	20.81	21.39	22.37	22.56

Last Updated: February 28, 2025, 6:20 pm

Below is a detailed analysis of the quarterly data for Mphasis Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹3,561.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,536.00 Cr. (Sep 2024) to ₹3,561.00 Cr., marking an increase of ₹25.00 Cr..
For Expenses, as of Dec 2024, the value is ₹2,883.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,888.00 Cr. (Sep 2024) to ₹2,883.00 Cr., marking a decrease of 5.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹678.00 Cr.. The value appears strong and on an upward trend. It has increased from 648.00 Cr. (Sep 2024) to ₹678.00 Cr., marking an increase of ₹30.00 Cr..
For OPM %, as of Dec 2024, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 18.00% (Sep 2024) to 19.00%, marking an increase of 1.00%.
For Other Income, as of Dec 2024, the value is ₹63.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Sep 2024) to ₹63.00 Cr., marking an increase of ₹4.00 Cr..
For Interest, as of Dec 2024, the value is ₹39.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 40.00 Cr. (Sep 2024) to ₹39.00 Cr., marking a decrease of 1.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹132.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 104.00 Cr. (Sep 2024) to ₹132.00 Cr., marking an increase of ₹28.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹569.00 Cr.. The value appears strong and on an upward trend. It has increased from 563.00 Cr. (Sep 2024) to ₹569.00 Cr., marking an increase of ₹6.00 Cr..
For Tax %, as of Dec 2024, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 25.00%.
For Net Profit, as of Dec 2024, the value is ₹428.00 Cr.. The value appears strong and on an upward trend. It has increased from 423.00 Cr. (Sep 2024) to ₹428.00 Cr., marking an increase of ₹5.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 22.56. The value appears strong and on an upward trend. It has increased from ₹22.37 (Sep 2024) to 22.56, marking an increase of ₹0.19.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:27 pm

Metric	Oct 2013	Mar 2014n n 5m	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	5,796	2,594	5,795	6,081	6,076	6,546	7,731	8,844	9,722	11,961	13,798	13,279	13,932
Expenses	4,764	2,154	4,925	5,218	5,108	5,483	6,407	7,193	7,919	9,844	11,365	10,857	11,349
Operating Profit	1,033	440	870	863	969	1,062	1,324	1,650	1,803	2,118	2,434	2,422	2,583
OPM %	18%	17%	15%	14%	16%	16%	17%	19%	19%	18%	18%	18%	19%
Other Income	140	44	194	172	223	149	177	178	133	160	162	218	259
Interest	33	11	28	24	14	13	17	81	63	74	97	161	179
Depreciation	145	50	98	121	79	71	76	232	242	291	325	410	472
Profit before tax	995	422	938	890	1,099	1,128	1,407	1,515	1,631	1,913	2,173	2,068	2,191
Tax %	25%	28%	28%	29%	28%	26%	24%	22%	25%	25%	25%	25%
Net Profit	744	303	675	632	792	838	1,073	1,185	1,217	1,431	1,638	1,555	1,649
EPS in Rs	35.40	14.40	32.10	30.05	37.62	43.34	57.64	63.52	65.06	76.19	86.94	82.27	87.13
Dividend Payout %	48%	49%	50%	67%	45%	46%	47%	55%	100%	60%	58%	67%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-6.37%	25.32%	5.81%	28.04%	10.44%	2.70%	17.58%	14.47%	-5.07%
Change in YoY Net Profit Growth (%)	0.00%	31.69%	-19.51%	22.23%	-17.60%	-7.74%	14.88%	-3.12%	-19.53%

Mphasis Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	18%
5 Years:	11%
3 Years:	11%
TTM:	5%

Compounded Profit Growth
10 Years:	17%
5 Years:	8%
3 Years:	8%
TTM:	5%

Stock Price CAGR
10 Years:	19%
5 Years:	25%
3 Years:	-12%
1 Year:	-8%

Return on Equity
10 Years:	18%
5 Years:	20%
3 Years:	20%
Last Year:	18%

Last Updated: Unknown

Balance Sheet

Last Updated: January 13, 2025, 3:12 pm

Month	Oct 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	210	210	210	210	210	193	186	187	187	188	188	189	189
Reserves	4,724	4,905	5,270	5,645	5,942	5,289	5,064	5,643	6,340	6,755	7,746	8,606	8,480
Borrowings	554	540	575	461	260	390	543	571	513	527	198	1,544	1,820
Other Liabilities	1,601	1,320	1,312	1,092	889	1,109	1,576	2,339	2,324	3,214	3,373	3,662	3,092
Total Liabilities	7,090	6,974	7,367	7,408	7,301	6,980	7,368	8,740	9,365	10,684	11,506	14,000	13,582
Fixed Assets	2,462	2,404	2,334	1,597	1,921	1,884	2,170	3,013	3,020	3,774	4,060	5,533	5,558
CWIP	26	6	20	56	1	2	3	17	3	11	32	61	0
Investments	1,899	1,815	1,443	2,122	2,396	1,782	1,329	1,326	1,846	1,813	1,753	3,090	2,123
Other Assets	2,702	2,748	3,569	3,633	2,983	3,312	3,866	4,384	4,496	5,087	5,662	5,316	5,901
Total Assets	7,090	6,974	7,367	7,408	7,301	6,980	7,368	8,740	9,365	10,684	11,506	14,000	13,582

Below is a detailed analysis of the balance sheet data for Mphasis Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹189.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹189.00 Cr..
For Reserves, as of Sep 2024, the value is ₹8,480.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹8,606.00 Cr. (Mar 2024) to ₹8,480.00 Cr., marking a decrease of 126.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹1,820.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹1,544.00 Cr. (Mar 2024) to ₹1,820.00 Cr., marking an increase of 276.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹3,092.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹3,662.00 Cr. (Mar 2024) to ₹3,092.00 Cr., marking a decrease of 570.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹13,582.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹14,000.00 Cr. (Mar 2024) to ₹13,582.00 Cr., marking a decrease of 418.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹5,558.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹5,533.00 Cr. (Mar 2024) to ₹5,558.00 Cr., marking an increase of 25.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹61.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 61.00 Cr..
For Investments, as of Sep 2024, the value is ₹2,123.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹3,090.00 Cr. (Mar 2024) to ₹2,123.00 Cr., marking a decrease of 967.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹5,901.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹5,316.00 Cr. (Mar 2024) to ₹5,901.00 Cr., marking an increase of 585.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹13,582.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹14,000.00 Cr. (Mar 2024) to ₹13,582.00 Cr., marking a decrease of 418.00 Cr..

Notably, the Reserves (₹8,480.00 Cr.) exceed the Borrowings (1,820.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Oct 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	756	198	616	731	664	723	950	1,321	1,455	1,716	1,462	2,180
Cash from Investing Activity +	-483	225	-380	-175	267	507	280	142	-810	-271	196	-2,496
Cash from Financing Activity +	-318	-429	-186	-568	-710	-1,380	-1,342	-825	-861	-1,389	-1,440	77
Net Cash Flow	-45	-7	50	-12	221	-149	-112	638	-217	56	217	-239

Free Cash Flow

Month	Mar 2014n n 5m	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Oct 2013
Free Cash Flow	440.00	295.00	402.00	709.00	-389.00	-542.00	-570.00	-512.00	-525.00	-196.00	1.00	-553.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Oct 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	41	109	39	39	38	45	45	34	35	68	67	67
Inventory Days
Days Payable
Cash Conversion Cycle	41	109	39	39	38	45	45	34	35	68	67	67
Working Capital Days	-10	22	3	28	44	42	44	29	34	29	25	16
ROCE %	20%	8%	16%	15%	18%	19%	24%	26%	25%	27%	29%	24%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	55.80%	55.72%	55.70%	55.65%	55.63%	55.58%	55.57%	55.52%	55.45%	40.35%	40.32%	40.23%
FIIs	21.09%	20.48%	20.71%	18.89%	17.72%	17.19%	16.60%	15.72%	14.84%	18.32%	18.25%	20.78%
DIIs	18.04%	18.16%	17.78%	19.54%	21.00%	21.05%	22.55%	23.71%	24.63%	35.84%	36.87%	34.62%
Public	5.07%	5.64%	5.80%	5.93%	5.65%	6.19%	5.27%	5.06%	5.08%	5.49%	4.54%	4.38%
Others	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.03%	0.00%
No. of Shareholders	1,26,895	1,51,470	1,77,533	1,77,456	1,69,215	1,77,013	1,53,792	1,48,428	1,47,350	1,67,593	1,49,318	1,43,700

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
HDFC Mid-Cap Opportunities Fund - Regular Plan	3,376,960	1.18	771.33	1,000,000	2025-03-07	237.7%
Kotak Emerging Equity Fund - Regular Plan	2,053,594	1.04	469.06	1,000,000	2025-03-07	105.36%
Nippon India Growth Fund	1,000,000	0.82	228.41	1,000,000	2025-03-07	0%
Kotak Equity Opportunities Fund - Regular Plan	950,000	0.97	216.99	1,000,000	2025-03-07	-5%
HDFC Large and Mid Cap Fund - Regular Plan	900,734	1.06	205.74	1,000,000	2025-03-07	-9.93%
Franklin India Prima Fund	822,190	1.71	187.8	1,000,000	2025-03-07	-17.78%
Mirae Asset Midcap Fund	779,629	1.16	178.08	1,000,000	2025-03-07	-22.04%
Tata Digital India Fund	779,103	1.93	177.95	1,000,000	2025-03-07	-22.09%
Mirae Asset Focused Fund	762,360	2.2	174.13	1,000,000	2025-03-07	-23.76%
UTI Value Fund	750,000	1.88	171.31	1,000,000	2025-03-07	-25%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	82.42	87.05	76.38	65.18	63.57
Diluted EPS (Rs.)	81.83	86.37	75.61	64.43	63.09
Cash EPS (Rs.)	103.98	104.20	91.66	77.98	75.93
Book Value[Excl.RevalReserv]/Share (Rs.)	465.31	421.15	369.66	348.93	312.51
Book Value[Incl.RevalReserv]/Share (Rs.)	465.31	421.15	369.66	348.93	312.51
Revenue From Operations / Share (Rs.)	702.55	732.38	636.84	519.77	474.07
PBDIT / Share (Rs.)	139.66	137.76	121.29	103.49	98.00
PBIT / Share (Rs.)	117.94	120.50	105.81	90.56	85.59
PBT / Share (Rs.)	109.43	115.34	101.84	87.17	81.23
Net Profit / Share (Rs.)	82.26	86.94	76.18	65.05	63.52
NP After MI And SOA / Share (Rs.)	82.26	86.94	76.18	65.05	63.52
PBDIT Margin (%)	19.87	18.81	19.04	19.91	20.67
PBIT Margin (%)	16.78	16.45	16.61	17.42	18.05
PBT Margin (%)	15.57	15.74	15.99	16.77	17.13
Net Profit Margin (%)	11.70	11.87	11.96	12.51	13.39
NP After MI And SOA Margin (%)	11.70	11.87	11.96	12.51	13.39
Return on Networth / Equity (%)	17.67	20.64	20.60	18.64	20.32
Return on Capital Employeed (%)	22.45	25.76	25.32	23.34	24.24
Return On Assets (%)	11.00	14.10	13.30	12.94	13.53
Total Debt / Equity (X)	0.17	0.02	0.07	0.07	0.09
Asset Turnover Ratio (%)	1.03	1.05	0.90	0.75	0.67
Current Ratio (X)	1.58	2.13	1.96	2.40	2.04
Quick Ratio (X)	1.58	2.13	1.96	2.40	2.04
Dividend Payout Ratio (NP) (%)	60.64	52.82	85.08	53.66	42.46
Dividend Payout Ratio (CP) (%)	47.97	44.07	70.71	44.76	35.51
Earning Retention Ratio (%)	39.36	47.18	14.92	46.34	57.54
Cash Earning Retention Ratio (%)	52.03	55.93	29.29	55.24	64.49
Interest Coverage Ratio (X)	16.41	26.69	30.62	30.53	22.52
Interest Coverage Ratio (Post Tax) (X)	10.67	17.84	20.23	20.19	15.59
Enterprise Value (Cr.)	45867.38	32991.41	62998.79	32810.46	11841.36
EV / Net Operating Revenue (X)	3.45	2.39	5.27	3.37	1.34
EV / EBITDA (X)	17.38	12.71	27.65	16.95	6.48
MarketCap / Net Operating Revenue (X)	3.40	2.45	5.30	3.43	1.40
Retention Ratios (%)	39.35	47.17	14.91	46.33	57.53
Price / BV (X)	5.13	4.27	9.13	5.11	2.13
Price / Net Operating Revenue (X)	3.40	2.45	5.30	3.43	1.40
EarningsYield	0.03	0.04	0.02	0.03	0.09

After reviewing the key financial ratios for Mphasis Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 82.42. This value is within the healthy range. It has decreased from 87.05 (Mar 23) to 82.42, marking a decrease of 4.63.
For Diluted EPS (Rs.), as of Mar 24, the value is 81.83. This value is within the healthy range. It has decreased from 86.37 (Mar 23) to 81.83, marking a decrease of 4.54.
For Cash EPS (Rs.), as of Mar 24, the value is 103.98. This value is within the healthy range. It has decreased from 104.20 (Mar 23) to 103.98, marking a decrease of 0.22.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 465.31. It has increased from 421.15 (Mar 23) to 465.31, marking an increase of 44.16.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 465.31. It has increased from 421.15 (Mar 23) to 465.31, marking an increase of 44.16.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 702.55. It has decreased from 732.38 (Mar 23) to 702.55, marking a decrease of 29.83.
For PBDIT / Share (Rs.), as of Mar 24, the value is 139.66. This value is within the healthy range. It has increased from 137.76 (Mar 23) to 139.66, marking an increase of 1.90.
For PBIT / Share (Rs.), as of Mar 24, the value is 117.94. This value is within the healthy range. It has decreased from 120.50 (Mar 23) to 117.94, marking a decrease of 2.56.
For PBT / Share (Rs.), as of Mar 24, the value is 109.43. This value is within the healthy range. It has decreased from 115.34 (Mar 23) to 109.43, marking a decrease of 5.91.
For Net Profit / Share (Rs.), as of Mar 24, the value is 82.26. This value is within the healthy range. It has decreased from 86.94 (Mar 23) to 82.26, marking a decrease of 4.68.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 82.26. This value is within the healthy range. It has decreased from 86.94 (Mar 23) to 82.26, marking a decrease of 4.68.
For PBDIT Margin (%), as of Mar 24, the value is 19.87. This value is within the healthy range. It has increased from 18.81 (Mar 23) to 19.87, marking an increase of 1.06.
For PBIT Margin (%), as of Mar 24, the value is 16.78. This value is within the healthy range. It has increased from 16.45 (Mar 23) to 16.78, marking an increase of 0.33.
For PBT Margin (%), as of Mar 24, the value is 15.57. This value is within the healthy range. It has decreased from 15.74 (Mar 23) to 15.57, marking a decrease of 0.17.
For Net Profit Margin (%), as of Mar 24, the value is 11.70. This value exceeds the healthy maximum of 10. It has decreased from 11.87 (Mar 23) to 11.70, marking a decrease of 0.17.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 11.70. This value is within the healthy range. It has decreased from 11.87 (Mar 23) to 11.70, marking a decrease of 0.17.
For Return on Networth / Equity (%), as of Mar 24, the value is 17.67. This value is within the healthy range. It has decreased from 20.64 (Mar 23) to 17.67, marking a decrease of 2.97.
For Return on Capital Employeed (%), as of Mar 24, the value is 22.45. This value is within the healthy range. It has decreased from 25.76 (Mar 23) to 22.45, marking a decrease of 3.31.
For Return On Assets (%), as of Mar 24, the value is 11.00. This value is within the healthy range. It has decreased from 14.10 (Mar 23) to 11.00, marking a decrease of 3.10.
For Total Debt / Equity (X), as of Mar 24, the value is 0.17. This value is within the healthy range. It has increased from 0.02 (Mar 23) to 0.17, marking an increase of 0.15.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.03. It has decreased from 1.05 (Mar 23) to 1.03, marking a decrease of 0.02.
For Current Ratio (X), as of Mar 24, the value is 1.58. This value is within the healthy range. It has decreased from 2.13 (Mar 23) to 1.58, marking a decrease of 0.55.
For Quick Ratio (X), as of Mar 24, the value is 1.58. This value is within the healthy range. It has decreased from 2.13 (Mar 23) to 1.58, marking a decrease of 0.55.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 60.64. This value exceeds the healthy maximum of 50. It has increased from 52.82 (Mar 23) to 60.64, marking an increase of 7.82.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 47.97. This value is within the healthy range. It has increased from 44.07 (Mar 23) to 47.97, marking an increase of 3.90.
For Earning Retention Ratio (%), as of Mar 24, the value is 39.36. This value is below the healthy minimum of 40. It has decreased from 47.18 (Mar 23) to 39.36, marking a decrease of 7.82.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 52.03. This value is within the healthy range. It has decreased from 55.93 (Mar 23) to 52.03, marking a decrease of 3.90.
For Interest Coverage Ratio (X), as of Mar 24, the value is 16.41. This value is within the healthy range. It has decreased from 26.69 (Mar 23) to 16.41, marking a decrease of 10.28.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 10.67. This value is within the healthy range. It has decreased from 17.84 (Mar 23) to 10.67, marking a decrease of 7.17.
For Enterprise Value (Cr.), as of Mar 24, the value is 45,867.38. It has increased from 32,991.41 (Mar 23) to 45,867.38, marking an increase of 12,875.97.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.45. This value exceeds the healthy maximum of 3. It has increased from 2.39 (Mar 23) to 3.45, marking an increase of 1.06.
For EV / EBITDA (X), as of Mar 24, the value is 17.38. This value exceeds the healthy maximum of 15. It has increased from 12.71 (Mar 23) to 17.38, marking an increase of 4.67.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.40. This value exceeds the healthy maximum of 3. It has increased from 2.45 (Mar 23) to 3.40, marking an increase of 0.95.
For Retention Ratios (%), as of Mar 24, the value is 39.35. This value is within the healthy range. It has decreased from 47.17 (Mar 23) to 39.35, marking a decrease of 7.82.
For Price / BV (X), as of Mar 24, the value is 5.13. This value exceeds the healthy maximum of 3. It has increased from 4.27 (Mar 23) to 5.13, marking an increase of 0.86.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.40. This value exceeds the healthy maximum of 3. It has increased from 2.45 (Mar 23) to 3.40, marking an increase of 0.95.
For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Mphasis Ltd as of March 10, 2025 is: ₹1,825.27

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 10, 2025, Mphasis Ltd is Overvalued by 20.71% compared to the current share price 2,302.00

Intrinsic Value of Mphasis Ltd as of March 10, 2025 is: 1,935.08

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 10, 2025, Mphasis Ltd is Overvalued by 15.94% compared to the current share price 2,302.00

Last 5 Year EPS CAGR: 6.02%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 20.92%, which is a positive sign. The stock has a low average Working Capital Days of 25.50, which is a positive sign. The company has higher reserves (6,185.31 cr) compared to borrowings (653.54 cr), indicating strong financial stability. The company has shown consistent growth in sales (8.00 cr) and profit (250.54 cr) over the years.	The stock has a high average Cash Conversion Cycle of 52.25, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mphasis Ltd:
1. Net Profit Margin: 11.7%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 22.45% (Industry Average ROCE: 20.31%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 17.67% (Industry Average ROE: 16.92%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 10.67
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.58
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 26.5 (Industry average Stock P/E: 44.27)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.17
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

MphasiS Ltd. is a Public Limited Listed company incorporated on 10/08/1992 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L30007KA1992PLC025294 and registration number is 025294. Currently Company is involved in the business activities of Computer programming activities. Company's Total Operating Revenue is Rs. 9092.97 Cr. and Equity Capital is Rs. 189.01 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
IT Consulting & Software	Bagmane World Technology Center, Bengaluru Karnataka 560048	investor.relations@mphasis.com http://www.mphasis.com

Management
Name	Position Held
Mr. Davinder Singh Brar	Chairman
Mr. Nitin Rakesh	Managing Director & CEO
Mr. Maureen Anne Erasmus	Director
Mr. Amit Dalmia	Director
Mr. Amit Dixit	Director
Mr. Sunil Gulati	Director
Ms. Jan Kathleen Hier	Director
Mr. Kabir Mathur	Director
Mr. Pankaj Sood	Director
Mr. Courtney Della Cava	Director
Mr. Marshall Jan Lux	Director
Mr. David Lawrence Johnson	Director

FAQ

What is the latest intrinsic value of Mphasis Ltd?

The latest intrinsic value of Mphasis Ltd as on 10 March 2025 is ₹1825.27, which is 20.71% lower than the current market price of 2,302.00, indicating the stock is overvalued by 20.71%. The intrinsic value of Mphasis Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹43,737 Cr. and recorded a high/low of ₹3,240/2,173 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹8,480 Cr and total liabilities of ₹13,582 Cr.

What is the Market Cap of Mphasis Ltd?

The Market Cap of Mphasis Ltd is 43,737 Cr..

What is the current Stock Price of Mphasis Ltd as on 10 March 2025?

The current stock price of Mphasis Ltd as on 10 March 2025 is ₹2,302.

What is the High / Low of Mphasis Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Mphasis Ltd stocks is ₹3,240/2,173.

What is the Stock P/E of Mphasis Ltd?

The Stock P/E of Mphasis Ltd is 26.5.

What is the Book Value of Mphasis Ltd?

The Book Value of Mphasis Ltd is 457.

What is the Dividend Yield of Mphasis Ltd?

The Dividend Yield of Mphasis Ltd is 2.39 %.

What is the ROCE of Mphasis Ltd?

The ROCE of Mphasis Ltd is 24.0 %.

What is the ROE of Mphasis Ltd?

The ROE of Mphasis Ltd is 18.4 %.

What is the Face Value of Mphasis Ltd?

The Face Value of Mphasis Ltd is 10.0.